VANGUARD GROUP INC - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$99,788
-85.8%
206,900
-84.5%
0.00%
Q4 2022$704,606
+1.8%
1,335,746
-2.7%
0.00%
Q3 2022$692,000
-71.7%
1,373,0120.0%0.00%
Q2 2022$2,444,000
+165.7%
1,373,012
-1.5%
0.00%
Q1 2022$920,000
-27.7%
1,393,5120.0%0.00%
Q4 2021$1,273,000
-78.2%
1,393,512
-2.1%
0.00%
Q3 2021$5,850,000
-5.0%
1,423,382
+0.1%
0.00%
Q2 2021$6,159,000
-20.3%
1,422,331
-7.2%
0.00%
Q1 2021$7,727,000
+24.6%
1,532,945
+56.0%
0.00%
Q4 2020$6,199,000
+57.0%
982,403
+7.0%
0.00%
Q3 2020$3,948,000
-28.1%
918,427
-1.9%
0.00%
Q2 2020$5,494,000
+89.0%
936,062
+40.7%
0.00%
Q1 2020$2,907,000
-29.3%
665,299
+10.3%
0.00%
Q4 2019$4,109,000
+38.7%
603,2970.0%0.00%
Q3 2019$2,962,000
-32.1%
603,297
+1.9%
0.00%
Q2 2019$4,363,000
-3.7%
592,039
+6.0%
0.00%
Q1 2019$4,529,000
+137.4%
558,535
+130.9%
0.00%
Q4 2018$1,908,000
-67.9%
241,876
-56.2%
0.00%
Q3 2018$5,947,000
-8.0%
551,684
-0.4%
0.00%
Q2 2018$6,467,000
-32.4%
554,137
+49.5%
0.00%
Q1 2018$9,562,000
+652.3%
370,603
+297.8%
0.00%
Q4 2017$1,271,000
+339.8%
93,152
+62.4%
0.00%
Q3 2017$289,000
+41.7%
57,367
+31.2%
0.00%
Q2 2017$204,000
+96.2%
43,714
+294.1%
0.00%
Q1 2017$104,00011,0930.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,635,014$10,830,0004.93%
22NW, LP 1,429,242$5,874,0001.75%
Ghost Tree Capital, LLC 1,000,000$4,110,0001.20%
Sio Capital Management, LLC 623,892$2,564,0000.82%
ACUTA CAPITAL PARTNERS, LLC 365,000$1,500,0000.53%
Nantahala Capital Management 2,432,212$9,996,0000.32%
Parkman Healthcare Partners LLC 133,449$548,0000.14%
Ikarian Capital, LLC 454,346$1,867,0000.13%
Orbimed Advisors 2,711,600$11,145,0000.12%
AlphaCentric Advisors LLC 114,000$469,0000.12%
View complete list of CATALYST BIOSCIENCES INC shareholders